Drug Manufacturers - Specialty & Generic
CPIX
3.40
price down icon2.86%   -0.10
after-market Handel nachbörslich: 3.40

Cumberland Pharmaceuticals Inc (CPIX)
full-star
loading
Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit
Schlusskurs vom Vortag:
$3.50
Offen:
$3.5
24-Stunden-Volumen:
30,379
Relative Volume:
0.45
Marktkapitalisierung:
$50.87M
Einnahmen:
$37.79M
Nettoeinkommen (Verlust:
$-10.38M
KGV:
-4.6575
EPS:
-0.73
Netto-Cashflow:
$-1.00M
1W Leistung:
-2.86%
1M Leistung:
-21.84%
6M Leistung:
+29.77%
1J Leistung:
+129.73%
1-Tages-Spanne:
Value
$3.275
$3.5718
1-Wochen-Bereich:
Value
$3.12
$3.965
52-Wochen-Spanne:
Value
$1.04
$7.25

Cumberland Pharmaceuticals Inc Stock (CPIX) Company Profile

Name
Firmenname
Cumberland Pharmaceuticals Inc
Name
Sektor
Healthcare (1161)
Name
Branche
Drug Manufacturers - Specialty & Generic (84)
Name
Telefon
615-255-0068
Name
Adresse
2525 WEST END AVENUE, NASHVILLE,, TN
Name
Mitarbeiter
91
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-04
Name
Neueste SEC-Einreichungen
Name
CPIX's Discussions on Twitter

Vergleichen Sie CPIX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
CPIX
Cumberland Pharmaceuticals Inc
 3.40 52.36M 37.79M -10.38M -1.00M -0.73
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
 151.19 68.05B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
 14.55 46.58B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
 9.65 43.71B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
 16.29 18.40B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
 297.89 13.23B 2.99B 1.21B 1.13B 25.06

Cumberland Pharmaceuticals Inc Stock (CPIX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2012-11-12 Bestätigt UBS Neutral
2011-02-01 Bestätigt UBS Neutral
2010-12-16 Herabstufung UBS Buy → Neutral
2010-08-17 Herabstufung Jefferies Buy → Hold
2010-08-17 Bestätigt Morgan Joseph Buy
2010-08-17 Bestätigt UBS Buy
2010-05-14 Bestätigt Morgan Joseph Buy
Alle ansehen

Cumberland Pharmaceuticals Inc Aktie (CPIX) Neueste Nachrichten

pulisher
Jul 22, 2025

What drives Cumberland Pharmaceuticals Inc. stock priceUnmatched market performance - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Cumberland Pharmaceuticals Inc. Stock Analysis and ForecastTremendous portfolio expansion - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Cumberland Pharmaceuticals Inc. stockBreakthrough investment results - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

Is Cumberland Pharmaceuticals Inc. a good long term investmentExceptional gains - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 19, 2025

how cumberland pharmaceuticals inc. stock performs during market volatilityFree Elite Traders Group - Newser

Jul 19, 2025
pulisher
Jul 18, 2025

Is Cumberland Pharmaceuticals Inc. stock a growth or value playSmart Money Trade Setups - Newser

Jul 18, 2025
pulisher
Jul 15, 2025

Why Cumberland Pharmaceuticals Inc. stock attracts strong analyst attentionROI Driven Alerts - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Cumberland Pharmaceuticals Inc. stock performs during market volatilityBest Stocks for Capital Safety - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Cumberland Pharmaceuticals Inc. stock price move sharplyChart Breakout Alert - Newser

Jul 15, 2025
pulisher
Jul 12, 2025

Caroline Young of Cumberland Pharmaceuticals buys CPIX shares By Investing.com - Investing.com Nigeria

Jul 12, 2025
pulisher
Jul 12, 2025

Caroline Young of Cumberland Pharmaceuticals buys CPIX shares - Investing.com Australia

Jul 12, 2025
pulisher
Jul 11, 2025

Cumberland Pharma CEO A J Kazimi buys shares worth $807 - Investing.com Australia

Jul 11, 2025
pulisher
Jul 11, 2025

Cumberland Pharma CEO A J Kazimi buys shares worth $807 By Investing.com - Investing.com Canada

Jul 11, 2025
pulisher
Jul 11, 2025

Cumberland Pharmaceuticals Advances Ifetroban Study for SSc and SSc-PAH - The Globe and Mail

Jul 11, 2025
pulisher
Jun 30, 2025

Cumberland Pharmaceuticals Inc.(NasdaqGS:CPIX) added to Russell Microcap Growth Index - MarketScreener

Jun 30, 2025
pulisher
Jun 23, 2025

Cumberland reports positive DMD heart drug trial results - Investing.com

Jun 23, 2025
pulisher
Jun 17, 2025

Asthma Market to Expand Significantly by 2034, States - openPR.com

Jun 17, 2025
pulisher
Jun 17, 2025

Asthma Market to Expand Significantly by 2034, States DelveInsight Report | GSK, AB Science, Areteia Therapeutics, ARS Pharma, AstraZeneca, Pieris Pharma, Sanofi, Cumberland Pharma, Genentech - Barchart.com

Jun 17, 2025
pulisher
Jun 14, 2025

Two Sigma Investments LP Has $89,000 Stake in Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) - Defense World

Jun 14, 2025
pulisher
Jun 12, 2025

Cumberland Pharmaceuticals (NASDAQ:CPIX) Shares Cross Above Two Hundred Day Moving Average – Here’s Why - Defense World

Jun 12, 2025
pulisher
Jun 06, 2025

Cumberland pharmaceuticals director Kenneth Krogulski acquires $4,824 in stock By Investing.com - Investing.com South Africa

Jun 06, 2025
pulisher
Jun 06, 2025

Cumberland pharmaceuticals director Kenneth Krogulski acquires $4,824 in stock - Investing.com

Jun 06, 2025

Finanzdaten der Cumberland Pharmaceuticals Inc-Aktie (CPIX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Ähnlich wie CPIX

drug_manufacturers_specialty_generic LNTH
$72.34
price up icon 1.09%
drug_manufacturers_specialty_generic ELAN
$14.93
price up icon 1.70%
drug_manufacturers_specialty_generic VTRS
$9.24
price up icon 3.82%
drug_manufacturers_specialty_generic RDY
$14.41
price down icon 0.96%
drug_manufacturers_specialty_generic NBIX
$132.75
price up icon 0.70%
drug_manufacturers_specialty_generic UTHR
$297.89
price up icon 1.63%
In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters
Kapitalisierung:     |  Volumen (24h):